ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MCGN Microgen

367.50
0.00 (0.00%)
09 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Microgen LSE:MCGN London Ordinary Share GB00BVVHWX30 ORD 6 3/7P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 367.50 365.00 370.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Microgen PLC Acquisition of RevStream (3757P)

31/08/2017 7:01am

UK Regulatory


Microgen (LSE:MCGN)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Microgen Charts.

TIDMMCGN

RNS Number : 3757P

Microgen PLC

31 August 2017

microgen

www.microgen.com 31 August 2017

ACQUISITION OF REVSTREAM INC.

Microgen plc ('Microgen') is pleased to announce the acquisition of RevStream Inc. ('RevStream'), a California-based provider of revenue management enterprise software. The acquisition broadens and complements the specialist capabilities within Microgen's Aptitude Software business ('Aptitude') and provides access to RevStream's growing client base in the technology sector.

RevStream will be integrated into Aptitude which already has an established office in Boston and a strong North American presence with over 50% of H1 2017 Aptitude revenues generated in the US and Canada.

Since 2015 Aptitude has established a market leading position in the telecommunications sector with the Aptitude Revenue Recognition Engine ('ARRE'), an application which enables organisations to address the requirements of IFRS 15 and ASC 606. ARRE has established this strong position as a result of its capability to process very rapidly a very high volume of complex, business event-driven transactions and calculations. The acquisition of RevStream enables Aptitude to offer broader revenue management functionality which augments the specialised capabilities of ARRE.

RevStream's growing client base, primarily focussed on the technology sector, complements Aptitude's strong presence within the financial services, insurance and telecommunications sectors and provides cross-selling opportunities for both organisations' products. In addition, RevStream's existing cloud capabilities will be leveraged across Aptitude's new applications where cloud deployment is appropriate.

Consideration for the entire issued and to be issued shares of RevStream is GBP9.7 million. In addition, at completion RevStream had debt and debt-like items of GBP2.5 million which Microgen will settle under its ownership. Of the consideration of GBP9.7 million, GBP7.7 million is expected to be payable in cash of which approximately 70% was paid on completion with the remaining 30% payable across the following two-year period. The initial cash consideration was satisfied using Microgen's existing cash resources. The consideration of GBP9.7 million also includes 421,582 Microgen shares (valued at GBP2.0 million as at 30 August 2017) which will be issued in August 2019. The founder, CEO and former majority shareholder of RevStream, Rajiv Chopra, will remain with the business.

RevStream has experienced a significant increase in demand for its products and services in 2017. RevStream's on-going recurring revenue base is currently GBP2.9 million, an increase of 58% since 31 December 2016, with a number of further opportunities well progressed. RevStream's revenue in the year ended 31 December 2016 was GBP2.7 million; this is expected to more than double in 2017. RevStream reported a loss before tax in 2016 of GBP0.8 million. The gross assets at 31 December 2016 were GBP0.9 million. The acquisition of RevStream is anticipated to be earnings enhancing in 2018.

Contacts

   Philip Wood, Chief Financial Officer                               020-7496-8100 
   James Melville-Ross / Darius Alexander                         020-3727-1000 

FTI Consulting

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACQGUGDIIBXBGRB

(END) Dow Jones Newswires

August 31, 2017 02:01 ET (06:01 GMT)

1 Year Microgen Chart

1 Year Microgen Chart

1 Month Microgen Chart

1 Month Microgen Chart

Your Recent History

Delayed Upgrade Clock